Will the new antipsychotics improve the treatment of schizophrenia?
- 25 September 1993
- Vol. 307 (6907) , 749-750
- https://doi.org/10.1136/bmj.307.6907.749-a
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.BMJ, 1993
- A two-year prospective study of treatment compliance in patients with schizophreniaPsychological Medicine, 1992
- Housing instability and homelessness among rural schizophrenic patientsAmerican Journal of Psychiatry, 1991
- Surreptitious Noncompliance With Oral Fluphenazine in a Voluntary Inpatient PopulationArchives of General Psychiatry, 1990
- Drug Prescribing for Schizophrenic Out-patients on Depot InjectionsThe British Journal of Psychiatry, 1990
- Insight and PsychosisThe British Journal of Psychiatry, 1990
- PSYCHOLOGICAL EFFECTS OF PREVIOUS TREATMENT EXPERIENCE WITH NEUROLEPTICS1990
- Why must some schizophrenic patients be involuntarily committed? The role of insightComprehensive Psychiatry, 1989
- Promoting Compliance With Outpatient Drug TreatmentPsychiatric Services, 1987
- Fluphenazine Decanoate, Fluphenazine Hydrochloride Given Orally, and Placebo in Remitted SchizophrenicsArchives of General Psychiatry, 1977